• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Keywords » anxiety disorders

Items Tagged with 'anxiety disorders'

ARTICLES

Clinical Update

Deep Rivers Run Quiet. An Update on Social Anxiety Disorder

March 8, 2023
Steven Hamilton, PhD, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Steven Hamilton, MD, PhD. The Permanente Medical Group, Department of Psychiatry, Kaiser Permanente San Francisco Medical Center. Dr. Hamilton has no financial relationships with companies related to this material.

SSRIs and CBT treat social anxiety disorder, but what do you do when they don’t work? Steven Hamilton describes 5 other pharmacotherapy options and shows us how to distinguish social anxiety from normal shyness.


Read More
EXPERT Q&A

Integrating Trauma-Informed Care into Addiction Treatment

October 31, 2022
Lydia Bartholow, DNP, PMHNP, CARN-AP
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

QA headshot_Bartholow.jpgLydia Bartholow, DNP, PMHNP, CARN-AP     

Medical Director, Central City Concern, Portland, OR. Assistant professor, University of California at San Francisco, San Francisco, CA.        

Dr. Bartholow, expert for this educational activity, has no financial relationship(s) with ineligible companies to disclose.

Trauma-informed care is a treatment approach that is gaining traction in the treatment of psychiatric disorders, including substance use disorders. Dr. Bartholow describes the underpinnings of trauma-informed care and reviews ways to integrate this approach into the treatment of patients with addiction.


Read More
RESEARCH UPDATE

Side Effects in Depression

October 30, 2022
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Fernando Espí Forcén, MD. Dr. Forcén has no financial relationships with companies related to this material.

Side effects are burdensome to patients, but do they also get in the way of recovery? This study sought to clarify how side effects change over time and whether they impede recovery in major depressive disorder.



Read More
RESEARCH UPDATE

Who Responds to SSRIs in PTSD?

October 30, 2022
Richard Moldawsky, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Richard Moldawsky, MD. Dr. Moldawsky has no financial relationships with companies related to this material.

SSRIs are often used in PTSD, but it is not clear that they work for all kinds of trauma. Trials of SSRIs are generally positive in women and people with a history of sexual trauma, while trials involving combat-related trauma tend to be negative. The current study aimed to better identify predictors of ­response.


Read More
CLINICAL UPDATE

Trichotillomania: Diagnosis and Treatment

October 30, 2022
Michael Posternak, MD.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Michael Posternak, MD. Psychiatrist in private practice, Boston, MA. Dr. Posternak has no financial relationships with companies related to this material.

Trichotillomania (TTM) is a disorder that seems to lurk in the shadows. We hear about it but rarely see it. 


Read More

Benzodiazepines: A Reevaluation of Their Benefits and Dangers

August 23, 2022
Carl Salzman MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Carl Salzman, MD

Professor of Psychiatry at Harvard Medical School and past chairman of the American Psychiatric Association Benzodiazepine Task Force. Interview by Marcia L. Zuckerman, MD. Board member of The Carlat Psychiatry Report; outpatient psychiatrist, Hallmark Health, Medford, MA; clinical assistant professor in psychiatry, Tufts School of Medicine. Edited by Chris Aiken, MD. Editor-in-Chief of TCPR; practicing psychiatrist, Winston-Salem, NC.

Drs. Salzman, Zuckerman, and Aiken have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Former Chairman of the American Psychiatric Association Benzodiazepine Task Force Carl Salzman explains the legitimate medical use of benzodiazepines and their relevance in psychiatric practice.


Read More
EXPERT Q&A

Benzodiazepines in Older Adults

April 1, 2022
Chris Aiken, MD
From The Carlat Geriatric Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Chris Aiken, MD.Chris Aiken, MD

Editor-in-Chief, The Carlat Psychiatry Report. Dr. Aiken specializes in mood disorders and works with older adults in private practice. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The best evidence for benzodiazepines in the elderly is in panic disorder, followed by phobias, social anxiety disorder, and generalized anxiety disorder. Benzodiazepines are also the mainstay of treating catatonia, rapid eye movement sleep behavior disorder, and alcohol withdrawal
Read More

A Longer Acting Lorazepam

March 4, 2022
Chris Aiken, MD.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. 
The straight facts on Loreev, a new extended-release formulation of lorazepam (Ativan).
Read More

An Off-Label Guide to Gabapentin

January 31, 2022
Rajesh R. Tampi, MD, MS, DFAPA. and Chris Aiken, MD.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Rajesh R. Tampi, MD, MS, DFAPA. Professor of Medicine, Case Western Reserve University. Chairman, Department of Psychiatry & Behavioral Sciences, Cleveland Clinic Akron General, and Chief of Geriatric Psychiatry, Cleveland Clinic. Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. The authors have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Off-label gabapentin (Neurontin) got a bad rep when it missed the mark in bipolar disorder, but there may be something worth salvaging in this drug. Here, we weigh its pros and cons for anxiety, substance use disorders, sleep, pain, and hot flashes, and compare it to its underutilized cousin, pregabalin (Lyrica).
Read More
CLINICAL UPDATE

Using Equine-Assisted Psychotherapy

October 18, 2021
Anja Kriegeskotten, MD, Peter Parry, MBBS, and Renee Sievert, RN, MFT,
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Anja Kriegeskotten, MD Psychiatrist in Australia, accredited equine therapist. Peter Parry, MBBS, consultant child and adolescent psychiatrist and senior lecturer at Flinders University in Adelaide, Australia. Renee Sievert, RN, MFT, certified equine therapist, CA.  Dr. Kriegeskotten, Dr. Parry, and Ms. Sievert have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Equine therapy is becoming popular for a variety of child and adolescent mental health problems, from ADHD, anxiety disorders and PTSD to developmental challenges. In this article our experts describe the nuts and bolts of equine assisted psychotherapy, covering the research and the practicalities of these approaches.
Read More
More Articles Tagged with 'anxiety disorders'
Introducing Carlat Total Access Subscriptions

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • AUDFB1e_CoilBound_Graphic2_transparent_sm.png

    (PRE-ORDER) Treating Alcohol Use Disorder—A Fact Book (2023)

    All the tools and information needed to assess and treat your patients who are struggling with...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.